Maira brings 20 years of academic and industry experience in R&D leadership, CMC development, regulatory strategy, clinical trial compliance, and data management across the pharmaceutical, medical device, and biotechnology sectors. She is a recognized subject matter expert in Canadian and U.S. regulatory frameworks, specializing in developing efficient market authorization pathways and ensuring clinical data integrity through evidence-based, compliant practices.

Her scientific background includes extensive research in immunology, bacterial genetics, probiotics, foodborne pathogens, and non-antibiotic alternatives that contribute to global efforts in combating antimicrobial resistance. Maira holds a Master of Science in Molecular Microbiology, a Ph.D. in Foodborne Zoonoses from the University of Guelph, and completed a postdoctoral fellowship in antibiotic resistance at McMaster University.

At SNI, she leverages her deep scientific foundation and regulatory expertise to guide the development of innovative, high-quality clinical research programs that bridge scientific discovery with real-world product compliance and commercialization.